This inventor holds 6 USPTO granted patents. Top assignees: Genetics Institute, Inc., Yale University, Other. Active years: 1997-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 392 
1 out of 1,368 
1 out of 834,570 Years Active: 1997-2005
Title: The Innovative Contributions of James Keith
Introduction
James Keith is a notable inventor based in Andover, MA (US), recognized for his significant contributions to the field of medical science. With a total of six patents to his name, he has made strides in developing treatments for various immune-mediated diseases.
Latest Patents
Among his latest patents is the invention titled "Use of interleukin-11 to prevent immune-mediated cytotoxicity." This patent discloses methods for using interleukin-11 to prevent, ameliorate, and treat immune-mediated diseases in mammals. Another significant patent is the "Method of using IL-11 for inflammation associated with acute pancreatitis." This invention provides methods for treating a variety of disorders, including AIDS, arthritis, multiple sclerosis, and asthma, among others.
Career Highlights
James Keith has worked with Genetics Institute, Inc., where he contributed to groundbreaking research and development in the medical field. His work has had a lasting impact on the treatment of various diseases, showcasing his dedication to improving health outcomes.
Collaborations
Throughout his career, James has collaborated with notable individuals such as Paul F. Schendel and Joseph M. Carroll, further enhancing the scope and impact of his inventions.
Conclusion
James Keith's innovative work and patents reflect his commitment to advancing medical science and improving patient care. His contributions continue to influence the field and inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile